SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-21-040123
Filing Date
2021-02-12
Accepted
2021-02-12 08:30:54
Documents
1
Group Members
PROSIGHT FUND, LPPROSIGHT PARTNERS, LLCPROSIGHT PLUS FUND, LPW. LAWRENCE HAWKINS

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d118952dsc13ga.htm SC 13G/A 105244
  Complete submission text file 0001193125-21-040123.txt   107092
Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Subject) CIK: 0001341235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88182 | Film No.: 21623014
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2301 CEDAR SPRINGS ROAD, SUITE 355 DALLAS TX 75201
Business Address 2301 CEDAR SPRINGS ROAD, SUITE 355 DALLAS TX 75201 214-468-0008
Prosight Management, LP (Filed by) CIK: 0001617201 (see all company filings)

IRS No.: 263706721 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A